In a regulatory filing, Tempus AI (TEM) disclosed that COO Ryan Fukushima sold 20,000 shares of the company’s stock. The stock was sold at an ...

To The Moon! Nancy Pelosi has made a number of shrewd investment moves lately, cashing in to the tune of a few million ...

Chief Operating Officer Ryan Fukushima recently sold a significant portion of his holdings in the company, according to a ...

TD Cowen analyst Dan Brennan reinstated coverage of Tempus AI (TEM) with a Buy rating and price target of $74, up from $58, following the ...

Tempus AI has delivered an 82% YTD return, outperforming the broader market and AI-themed stocks amidst market volatility.

Tempus AI's innovative products are transforming the healthcare industry, with a focus on oncology and large market ...

Noting that Ambry is a profitable testing laboratory that generates more than $300 million of revenue annually, the investment bank thinks that the deal will enable TEM to start generating positive ...

Experts say Investors may be valuing AI companies too generously if health systems can’t justify the costs of these tools.

Coming to the latest development around Olivia, the investors are optimistic, evident from the stock surge last week.

So, when the former Speaker placed a not-insignificant call options wager on TEM stock last month, momentum erupted. Over the trailing one-month period, TEM has gained almost 51% of equity value.

We recently published a list of Top 10 AI Stocks Trending On Wall Street. In this article, we are going to take a look at where Tempus AI, Inc.

Looking at options history for Tempus AI TEM we detected 21 trades. If we consider the specifics of each trade, it is ...